Maharashtra, India

Pramod Kadappa Shindey

This inventor holds 1 USPTO granted patent. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pramod Kadappa Shindey. Retrieved from https://idiyas.com/inventor/pramod-kadappa-shindey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pramod Kadappa Shindey: Innovator in Pharmaceutical Chemistry

Introduction

Pramod Kadappa Shindey is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new compounds and processes.

Latest Patents

One of his key patents is titled "Intermediates and processes for preparing Ticagrelor." This invention relates to new intermediates and processes for preparing Ticagrelor, a medication used to reduce the risk of heart attacks and strokes. The patent outlines a process for preparing Ticagrelor of Formula I, which involves coupling a compound of Formula VI with a compound of Formula IX.

Career Highlights

Pramod Kadappa Shindey is associated with Teva Pharmaceutical Industries Limited, a global leader in generic and specialty medicines. His work at Teva has allowed him to focus on innovative solutions in drug development.

Collaborations

He has collaborated with notable colleagues such as Vinod Kumar Kansal and Dhirenkumar Natvarial Mistry, contributing to advancements in pharmaceutical research.

Conclusion

Pramod Kadappa Shindey's contributions to the field of pharmaceutical chemistry, particularly through his patent on Ticagrelor, highlight his role as an innovator in the industry. His work continues to impact the development of essential medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…